Charles B. Hicks

Initial B-Cell Responses to Transmitted Human Immunodeficiency Virus Type 1: Virion-Binding Immunoglobulin M (IgM) and IgG Antibodies Followed by Plasma Anti-gp41 Antibodies with Ineffective Control of Initial Viremia

Georgia D. Tomaras, Nicole L. Yates, Pinghuang Liu et al. · Journal of Virology · 2008 · 618 citations · Full text

Immunology, Viral Dynamic, Plasma Virus +18

Durable efficacy of tipranavir-ritonavir in combination with an optimised background regimen of antiretroviral drugs for treatment-experienced HIV-1-infected patients at 48 weeks in the Randomized Evaluation of Strategic Intervention in multi-drug reSistant patients with Tipranavir (RESIST) studies: an analysis of combined data from two randomised open-label trials

Charles B. Hicks, Pedro Cahn, David A. Cooper et al. · The Lancet · 2006 · 322 citations

Durable Efficacy, Treatment-experienced Hiv-1-infected Patients, Hiv/aids Counselling +13

Heterogeneous neutralizing antibody and antibody-dependent cell cytotoxicity responses in HIV-1 elite controllers

Olivier Lambotte, Guido Ferrari, Christiane Moog et al. · AIDS · 2009 · 316 citations · Full text

High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men

Hui Li, Katharine J. Bar, Shuyi Wang et al. · PLoS Pathogens · 2010 · 297 citations · Full text

Seronegative Secondary Syphilis in a Patient Infected with the Human Immunodeficiency Virus (HIV) with Kaposi Sarcoma

Charles B. Hicks · Annals of Internal Medicine · 1987 · 274 citations

Primary Immunodeficiency, Seronegative Secondary Syphilis, Biopsy Samples +12